Enhanced chromatin accessibility contributes to X chromosome dosage compensation in mammals
Authors:
- Irene TalonITIrene Talon
- Adrian JaniszewskiAJAdrian Janiszewski
- Bart TheeuwesBTBart Theeuwes
- Thomas LefevreTLThomas Lefevre
- Juan SongJSJuan Song
- Greet BervoetsGBGreet Bervoets
- Lotte VanheerLVLotte Vanheer
- Natalie De GeestNGNatalie De Geest
- Suresh PoovathingalSPSuresh Poovathingal
- Ryan AllsopRARyan Allsop
- Jean-Christophe MarineJMJean-Christophe Marine
- Florian RambowFRFlorian Rambow
Open Access
- 1 November 2021
- journal article
- research article
- Published by Springer Nature in Genome Biology
- Vol. 22 (1) , 1-36
Abstract
Background: Precise gene dosage of the X chromosomes is critical for normal development and cellular function. In mice, XX female somatic cells show transcriptional X chromosome upregulation of their single active X chromosome, while the other X chromosome is inactive. Moreover, the inactive X chromosome is reactivated during development in the inner cell mass and in germ cells through X chromosome reactivation, which can be studied in vitro by reprogramming of somatic cells to pluripotency. How chromatin processes and gene regulatory networks evolved to regulate X chromosome dosage in the somatic state and during X chromosome reactivation remains unclear. Results: Using genome-wide approaches, allele-specific ATAC-seq and single-cell RNA-seq, in female embryonic fibroblasts and during reprogramming to pluripotency, we show that chromatin accessibility on the upregulated mammalian active X chromosome is increased compared to autosomes. We further show that increased accessibility on the active X chromosome is erased by reprogramming, accompanied by erasure of transcriptional X chromosome upregulation and the loss of increased transcriptional burst frequency. In addition, we characterize gene regulatory networks during reprogramming and X chromosome reactivation, revealing changes in regulatory states. Our data show that ZFP42/REX1, a pluripotency-associated gene that evolved specifically in placental mammals, targets multiple X-linked genes, suggesting an evolutionary link between ZFP42/REX1, X chromosome reactivation, and pluripotency. Conclusions: Our data reveal the existence of intrinsic compensatory mechanisms that involve modulation of chromatin accessibility to counteract X-to-Autosome gene dosage imbalances caused by evolutionary or in vitro X chromosome loss and X chromosome inactivation in mammalian cells.Keywords
Funding Information
- the Research Foundation–Flanders (G0F7716N, G0C9320N, G0B4420N, 1158318N)
- KU Leuven (StG/15/021BF)
- European Union’s Horizon 2020 (12T1217N)
- the Research Foundation–Flanders (1S72719N)
This publication has 123 references indexed in Scilit:
- Stage-Specific Regulation of Reprogramming to Induced Pluripotent Stem Cells by Wnt Signaling and T Cell Factor ProteinsCell Reports, 2013
- Mammalian X Upregulation Is Associated with Enhanced Transcription Initiation, RNA Half-Life, and MOF-Mediated H4K16 AcetylationDevelopmental Cell, 2013
- The Pluripotency Factor-Bound Intron 1 of Xist Is Dispensable for X Chromosome Inactivation and Reactivation In Vitro and In VivoCell Reports, 2013
- Rsx is a metatherian RNA with Xist-like properties in X-chromosome inactivationNature, 2012
- Histone variant macroH2A confers resistance to nuclear reprogrammingThe EMBO Journal, 2011
- Nanog Is the Gateway to the Pluripotent Ground StateCell, 2009
- Role of the Murine Reprogramming Factors in the Induction of PluripotencyCell, 2009
- Defining Molecular Cornerstones during Fibroblast to iPS Cell Reprogramming in MouseCell Stem Cell, 2008
- Evidence for nucleosome depletion at active regulatory regions genome-wideNature Genetics, 2004
- Requirement for Xist in X chromosome inactivationNature, 1996